entinostat has been researched along with Encephalopathy, Toxic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamoine, S | 1 |
| Cumenal, M | 1 |
| Barriere, DA | 1 |
| Pereira, V | 1 |
| Fereyrolles, M | 1 |
| Prival, L | 1 |
| Barbier, J | 1 |
| Boudieu, L | 1 |
| Brasset, E | 1 |
| Bertin, B | 1 |
| Renaud, Y | 1 |
| Miot-Noirault, E | 1 |
| Civiale, MA | 1 |
| Balayssac, D | 1 |
| Aissouni, Y | 1 |
| Eschalier, A | 1 |
| Busserolles, J | 1 |
1 other study available for entinostat and Encephalopathy, Toxic
| Article | Year |
|---|---|
The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Death; Cell Line, Tumor; Cell Proliferat | 2021 |